Cancer News and Research

Latest Cancer News and Research

New study to evaluate Pegasys and Copegus to treat hepatitis C in liver transplant patients

Roche has initiated a new study to evaluate treatment strategies to reduce post-transplant recurrence of hepatitis C infection with the most prescribed hepatitis C treatment combination in the U.S., Pegasys (peginterferon alfa-2a) and Copegus (ribavirin, USP).

21 Mar 2005

ParAllele BioScience announces key patent issuance

ParAllele BioScience has announced the issuance by the U.S. Patent Office of a key patent (6,858,412) covering its Molecular Inversion Probe (MIP) technology. The patent is owned by Stanford University and is exclusively licensed to ParAllele.

21 Mar 2005

New research in mice sheds light on the causes behind male infertility

For 40 percent of the estimated six million American couples battling infertility, the problem lies with the man. But help may be on the way.

21 Mar 2005

Scientists find microRNA regulates Ras cancer gene

Research in the laboratory of Assistant Professor Frank J. Slack at Yale University has identified a new way that a familiar gene is regulated in lung cancer, presenting new possibilities for diagnosis and treatment. The work is reported in March issues of the journals Cell and Developmental Cell.

21 Mar 2005

Demonstrating cost and clinical benefits critical to expansion of European seed brachytherapy markets

The nascent European seed brachytherapy market has been grappling with issues of high procedural and investment costs and a lack of local clinical evidence. However, growing evidence of the overall clinical and cost benefits of seed brachytherapy coupled with rising patient awareness is set to boost market expansion.

21 Mar 2005

Rapid rise in obesity may reverse life expectancy trend

It's been assumed that U.S. life expectancy would rise indefinitely, but a new data analysis, published as a special report in the March 17 New England Journal of Medicine, suggests that this trend is about to reverse itself -- due to the rapid rise in obesity, especially among children.

21 Mar 2005

Psychiatric diagnostic criteria fail to identify psychological suffering in oncology

A group of researchers of the University of Ferrara studied the psychological and psychosomatic distress associated with cancer in the march issue of Psychotherapy and Psychosomatics.

21 Mar 2005

NHS Stop-Smoking Services are insufficient to deliver national smoking targets

NHS Stop-Smoking Services are insufficient to deliver national smoking targets, and Government smoking targets are themselves insufficient for the poorest communities, says a study published online by the BMJ.

21 Mar 2005

Anti-smoking cinema advertising campaign aimed at young people launched in South Australia

An anti-smoking cinema advertising campaign aimed at young people was launched in South Australia yesterday as part of National Youth Tobacco Free Day.

16 Mar 2005

Conference to assess evidence on management of menopause-related symptoms

The National Institutes of Health (NIH) will hold a State-of-the-Science Conference on Management of Menopause-Related Symptoms, March 21-23, 2005, at the Natcher Conference Center on the NIH campus in Bethesda, Maryland.

16 Mar 2005

Parents should be banned from smoking while driving with children

Parents should be banned from smoking while driving with children in their vehicle, the Australian Medical Association (WA) said yesterday.

16 Mar 2005

RNAi Consortium to accelerate genetic research

Whitehead Institute has joined ten other leading biomedical organizations in an $18 million, three-year public-private consortium that will create a comprehensive library of gene inhibitors to be made available to the entire scientific community.

16 Mar 2005

Approval for Temodar (temozolomide) capsules for newly diagnosed glioblastoma multiforme

Schering-Plough today reported that the U.S. Food and Drug Administration (FDA) has granted approval for Temodar (temozolomide) Capsules for use in combination with radiotherapy for the treatment of adult patients with newly diagnosed glioblastoma multiforme (GBM), a form of malignant brain cancer.

16 Mar 2005

Risk of cardiac death after radiation for breast cancer has dramatically decreased

In the largest and most comprehensive prospective study of its kind, researchers at The University of Texas M. D. Anderson Cancer Center have concluded that the risk of ischemic heart disease and, ultimately, cardiac death following radiation treatment for breast cancer has steadily declined over the last quarter century.

16 Mar 2005

Uncertainty about the need for prostate cancer

Initial results from an ongoing study evaluating the benefit of prostate cancer screening practices demonstrate that the combined use of both standard tests - the prostate-specific antigen (PSA) blood test and the digital rectal exam (DRE) - is optimal for detecting cancer.

16 Mar 2005

Cancer survival comes at its own price

Patients who hear the dreaded words "you have cancer" invariably look forward to the day the doctor tells them "you're cured." But University of Florida researchers say survival often comes at its own price -- the mind may need mending even after the body heals.

16 Mar 2005

Risky surgery not always necessary to treat cervical disease

Revolutionary advancements in the treatment options for diseases associated with human papillomavirus (HPV) now include nonsurgical options such as chemoprevention and vaccines. A review of these methods is published in the latest issue of the International Journal of Gynecological Cancer.

16 Mar 2005

More research on Vitamin E surprises scientists

50 years of research into the supposed benefits of taking vitamin E has extolled its antioxidant potential to offer a variety of potential health benefits, including reducing the risk of Alzheimer's, cancer and heart disease.

15 Mar 2005

Vitamin E may increase heart attack risk - does not prevent cancer

A study by Canadian researchers Eva Lonn, M.D., of the Population Health Research Institute and McMaster University, Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada, and colleagues, has found from examining experimental and epidemiological data, that patients who took vitamin E supplements for 7 years did not significantly reduce their risk of cancer or cardiovascular events and some in fact had an increased risk of heart failure.

15 Mar 2005

Drug combo gives lung cancer patients longer life

Preliminary results from a large randomized clinical trial, sponsored by the National Cancer Institute (NCI), by a network of researchers led by the Eastern Cooperative Oncology Group. Genentech, Inc., have shown that patients with previously untreated advanced non-squamous non-small cell lung cancer who received bevacizumab (Avastin) in combination with standard chemotherapy lived longer than patients who received the same chemotherapy without bevacizumab.

15 Mar 2005